Collectively, these findings indicate that sustained NMT1 activity is necessary for LAMTOR1-dependent lysosomal localization of mTORC1, and that lysosomal mTORC1 localization and activation can be effectively disrupted with a small molecule inhibitor of NMT in cancer cells. This evidence concerns the gene LAMTOR1 and cancer.